Saliva Diagnostics (US) plans mid-February launch for Hema*Strip:
This article was originally published in Clinica
Executive Summary
Saliva Diagnostics (US) plans to launch its Hema*Strip HIV-1/2 test in Asia in February. The simple, self contained assay will be manufactured in Singapore and the first exports are scheduled for India, through the Fremont Group, and China, through local representatives. However, SDS admits that production capacity is currently limited.